A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Sodium thiosulfate (Primary)
- Indications Calciphylaxis
- Focus Registrational; Therapeutic Use
- Acronyms CALISTA
- Sponsors Hope Pharmaceuticals
- 18 Nov 2018 Planned End Date changed from 1 May 2019 to 24 May 2020.
- 18 Nov 2018 Planned primary completion date changed from 1 May 2019 to 24 May 2020.
- 18 Nov 2018 Status changed from discontinued to recruiting.